1 documents found
Information × Registration Number 0218U003839, 0115U000236 , R & D reports Title Optimizing treatment of nonalcoholic fatty liver disease on a background of hypertension based on metabolic, vascular gene polymorphism and aspects AGTR1 popup.stage_title Head Oleg Babak, Registration Date 07-08-2018 Organization 3.Kharkov national medical university popup.description2 It is determined that in patients with NAFLD against the background of the hypertension there is a carbohydrate and lipid metabolism disorder, increased level of visfatin and adiponectin, endothelium-dependent vasodilation and raising levels of TNF- ? and enterleukin-1. More severe changes were observed for patients with allele C of the AGTR-1. With the purpose of correction of the determined disorders a chart of the combined therapy has been developed that includes application of atorvastatin, lisinopril, UDCA and omega-3 fatty acids which, along with modification of lifestyle, has helped to reduce the overall cardiometabolic risk and improve life expectancy in patients with non-alcoholic fatty liver disease combined with arterial hypertension. Product Description popup.authors Андрєєва А.О. Більченко А.О. Бабак О.Я. Башкірова Г.Д. Візір М.О. Голенко Т.М. Гопцій О.В. Железнякова Н.М. Зайченко О.Є. Зелена І.І. Кірієнко М.О. Клименко М.І. Лапшина К.А. Молодан В.І. Овчаренко Л.І. Панченко Г.Ю. Просоленко К.О. Ситник К.О. Фролова-Романюк Е.Ю. Черних В.В. popup.nrat_date 2020-04-02 Close
R & D report
Optimizing treatment of nonalcoholic fatty liver disease on a background of hypertension based on metabolic, vascular gene polymorphism and aspects AGTR1
1
Head: Oleg Babak. Optimizing treatment of nonalcoholic fatty liver disease on a background of hypertension based on metabolic, vascular gene polymorphism and aspects AGTR1. (popup.stage: ). 3.Kharkov national medical university. № 0218U003839
1 documents found

Updated: 2026-03-27


Роздрукувати цю сторінку